In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Dirk Lange, Head of Life Science Services at MilliporeSigma.
Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Dirk, covering:
What he has learned from 25 years of bouncing around geographically in terms of cultural differences in understanding clients and colleagues
Life on both sides of the fence as a drug sponsor and a CDMO, including key dynamics a buyer has to consider
How MilliporeSigma has focused on ‘nesting’ its testing services, leading to the use of ’CTDMO'
Insights into future trends including the need to deal with novel modalities in an agile way and digitally transform where possible

Dirk Lange is the Head of Life Science Services at the Life Science business of Merck KGaA, Darmstadt, Germany where he oversees the fully integrated Contract Testing, Development, and Manufacturing Organization (CTDMO) and Contract Testing services for the Life Science business.
He has over two decades of experience in life science client services organizations and an extensive background in clinical and commercial operations. He has held leadership roles at companies such as KBI Biopharma, Selexis SA, Novartis Biologics, Sandoz Oncology Injectables, and Rentschler Biopharma.
 
Lange received his Master Professional (CCI) of Technical Management and his Bachelor Professional (CCI) of Pharmaceutical Technology. He also taught Economics and Operations Management at the Chamber of Commerce and Industry in Ulm, Germany.
Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!
Molecule to Market is sponsored and funded by ramarketing. An international content, design and digital agency that helps companies in life sciences, get noticed.